← Explore
Vertex Pharmaceuticals
VRTX
$550.64
per share, on-chain
What Vertex Pharmaceuticals does
Vertex Pharmaceuticals Incorporated is a global biotechnology company focused on developing transformative medicines for serious diseases, including cystic fibrosis, sickle cell disease, and acute pain, with key products such as TRIKAFTA and CASGEVY.
- Industry
- Healthcare
- CEO
- Reshma Kewalramani
- Website
- vrtx.com
Ways to own Vertex Pharmaceuticals
There's one version of this stock on Firstshare.
OndoVRTXonOur pick
Wider choice. Usually $20 minimum, and it can cost more when New York is closed.
Daily backing report (29 Oct) ↗Monthly backing report (Sep 2026) ↗
$550.64
Open, outside US hours
Price check
What a slice looks like
$10.00 buys you 0.018 of one Vertex Pharmaceuticals share.
That's 1.8% of one share. Small, but it's yours, and it moves with the real price. One share costs $550.64.